ArticleInfection and immunity2009

Genetically modified L3,7 and L2 lipooligosaccharides from Neisseria meningitidis serogroup B confer a broad cross-bactericidal response.

V Weynants et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.